302 related articles for article (PubMed ID: 19084149)
1. Cost of bloodstream infections.
Kilgore M; Brossette S
Am J Infect Control; 2008 Dec; 36(10):S172.e1-3. PubMed ID: 19084149
[TBL] [Abstract][Full Text] [Related]
2. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
3. The costs of nosocomial infections.
Kilgore ML; Ghosh K; Beavers CM; Wong DY; Hymel PA; Brossette SE
Med Care; 2008 Jan; 46(1):101-4. PubMed ID: 18162862
[TBL] [Abstract][Full Text] [Related]
4. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
5. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
6. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients.
Elward AM; Hollenbeak CS; Warren DK; Fraser VJ
Pediatrics; 2005 Apr; 115(4):868-72. PubMed ID: 15805357
[TBL] [Abstract][Full Text] [Related]
7. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Crnich CJ
Am J Infect Control; 2003 Dec; 31(8):475-80. PubMed ID: 14647110
[TBL] [Abstract][Full Text] [Related]
8. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
Digiovine B; Chenoweth C; Watts C; Higgins M
Am J Respir Crit Care Med; 1999 Sep; 160(3):976-81. PubMed ID: 10471627
[TBL] [Abstract][Full Text] [Related]
9. [A method to determine hospital costs associated with nosocomial infections].
Gianino MM; Vallino A; Anselmo E; Minniti D; Abbona F; Mineccia C; Silvaplana P; Zotti CM
Ann Ig; 2007; 19(4):381-92. PubMed ID: 17937330
[TBL] [Abstract][Full Text] [Related]
10. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.
Vandijck DM; Depaemelaere M; Labeau SO; Depuydt PO; Annemans L; Buyle FM; Oeyen S; Colpaert KE; Peleman RP; Blot SI; Decruyenaere JM
Int J Antimicrob Agents; 2008 Feb; 31(2):161-5. PubMed ID: 18164599
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia.
Eber MR; Laxminarayan R; Perencevich EN; Malani A
Arch Intern Med; 2010 Feb; 170(4):347-53. PubMed ID: 20177037
[TBL] [Abstract][Full Text] [Related]
12. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
13. Catheter-associated bloodstream infections: looking outside of the ICU.
Marschall J
Am J Infect Control; 2008 Dec; 36(10):S172.e5-8. PubMed ID: 19084150
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
Liu JW; Su YK; Liu CF; Chen JB
J Hosp Infect; 2002 Mar; 50(3):224-7. PubMed ID: 11886200
[TBL] [Abstract][Full Text] [Related]
15. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed.
Plowman R; Graves N; Griffin MA; Roberts JA; Swan AV; Cookson B; Taylor L
J Hosp Infect; 2001 Mar; 47(3):198-209. PubMed ID: 11247680
[TBL] [Abstract][Full Text] [Related]
16. The use of economic modeling to determine the hospital costs associated with nosocomial infections.
Roberts RR; Scott RD; Cordell R; Solomon SL; Steele L; Kampe LM; Trick WE; Weinstein RA
Clin Infect Dis; 2003 Jun; 36(11):1424-32. PubMed ID: 12766838
[TBL] [Abstract][Full Text] [Related]
17. A laboratory-based, hospital-wide, electronic marker for nosocomial infection: the future of infection control surveillance?
Brossette SE; Hacek DM; Gavin PJ; Kamdar MA; Gadbois KD; Fisher AG; Peterson LR
Am J Clin Pathol; 2006 Jan; 125(1):34-9. PubMed ID: 16482989
[TBL] [Abstract][Full Text] [Related]
18. The impact of nosocomial infections on hospital care costs.
Lauria FN; Angeletti C
Infection; 2003 Dec; 31 Suppl 2():35-43. PubMed ID: 15018471
[TBL] [Abstract][Full Text] [Related]
19. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury.
Niven DJ; Fick GH; Kirkpatrick AW; Grant V; Laupland KB
J Hosp Infect; 2010 Dec; 76(4):296-9. PubMed ID: 20705364
[TBL] [Abstract][Full Text] [Related]
20. Impact of nosocomial infection on cost of illness and length of stay in intensive care units.
Chen YY; Chou YC; Chou P
Infect Control Hosp Epidemiol; 2005 Mar; 26(3):281-7. PubMed ID: 15796281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
